Granville Capital

Granville Capital is an alternative investment management firm based in Greensboro, North Carolina, specializing in hedge funds and private equity fund-of-funds. Established in 2002, the firm manages capital for high-net-worth individuals and institutional investors, often providing exposure to the healthcare and life sciences sectors through its private equity allocations. While Granville Capital does not engage in direct drug discovery or development, it plays a role in the biotech ecosystem by investing in venture capital funds that support early-stage life science companies. The firm is known for its disciplined approach to manager selection and its focus on diversified alternative investment strategies. Its investment programs are designed to provide risk-adjusted returns that are less correlated with traditional equity and fixed-income markets.